Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gallinger

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
The American Journal of Surgical Pathology|October 19, 1999
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumorsV A Marcus, L Madlensky, R Gryfe, et al.
British Journal of Cancer|July 17, 2015
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenograftsI Lohse, A Borgida, P Cao, et al.
Carcinogenesis|October 19, 2007
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancerMiralem Mrkonjic, Stavroula Raptis, Roger C Green, et al.
Cell|August 23, 1996
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinomaK Eppert, S W Scherer, H Ozcelik, et al.
British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.
Gene Therapy|August 6, 1999
Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trialA K Stewart, N J Lassam, I C Quirt, et al.
Journal of the National Cancer Institute|March 22, 2007
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancerStavroula Raptis, Miralem Mrkonjic, Roger C Green, et al.
British Journal of Cancer|May 19, 2011
Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patientsJ B Rawson, M Mrkonjic, D Daftary, et al.
Human Genetics|April 6, 1999
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancerB V Bapat, L Madlensky, L K Temple, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2006
Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centreM Molinari, J R Kachura, E Dixon, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
The American Journal of Surgical Pathology|October 19, 1999
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumorsV A Marcus, L Madlensky, R Gryfe, et al.
British Journal of Cancer|July 17, 2015
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenograftsI Lohse, A Borgida, P Cao, et al.
Carcinogenesis|October 19, 2007
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancerMiralem Mrkonjic, Stavroula Raptis, Roger C Green, et al.
Cell|August 23, 1996
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinomaK Eppert, S W Scherer, H Ozcelik, et al.
British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.
Gene Therapy|August 6, 1999
Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trialA K Stewart, N J Lassam, I C Quirt, et al.
Journal of the National Cancer Institute|March 22, 2007
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancerStavroula Raptis, Miralem Mrkonjic, Roger C Green, et al.
British Journal of Cancer|May 19, 2011
Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patientsJ B Rawson, M Mrkonjic, D Daftary, et al.
Human Genetics|April 6, 1999
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancerB V Bapat, L Madlensky, L K Temple, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2006
Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centreM Molinari, J R Kachura, E Dixon, et al.
Pageof 15